1- (4- bromobenzoyl)- 3- (4- ferrocenylphenyl) urea

has anticonvulsant, anxiolytic, and sedative properties in mouse model

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Epilepsy (Aura) 01/01/2018 - "The molecular docking studies reveled that ferrocene compounds derivative 1-(4-bromobenzoyl)-3-(4-ferrocenylphenyl) urea (PB1) and cadmium compounds derivative bis (diphenylacetato) cadmium (II) (DPAA) exhibit binding affinities against various neurotherapeutic molecular targets involved in epilepsy, anxiety, and sedation. "